Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT

作者：Haimin Sun, Han Yan, Zeying Yan, Yongmei Zhu, Guang Yang, Sujiang Zhang · 发表于：Annals of Hematology · 年份：2022 · DOI：10.1007/s00277-022-05047-8 · 被引用次数：13 · 研究领域：Acute Myeloid Leukemia Research、Protein Degradation and Inhibitors、Sarcoma Diagnosis and Treatment